These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Bevacizumab (Avastin): An anti-angiogenic drug associated with osteonecrosis of the jaw. Wynn RL Gen Dent; 2011; 59(6):410-3. PubMed ID: 22313910 [No Abstract] [Full Text] [Related]
18. Tracheoesophageal fistula associated with bevacizumab 21 months after completion of radiation therapy. Gore E; Currey A; Choong N J Thorac Oncol; 2009 Dec; 4(12):1590-1. PubMed ID: 20009916 [No Abstract] [Full Text] [Related]
19. Tetany: possible adverse effect of bevacizumab. Anwikar SR; Bandekar MS; Patel TK; Patel PB; Kshirsagar NA Indian J Cancer; 2011; 48(1):31-3. PubMed ID: 21248449 [TBL] [Abstract][Full Text] [Related]
20. Correlation between rash and a positive drug response associated with bevacizumab in a patient with advanced colorectal cancer. Saif MW; Longo WL; Israel G Clin Colorectal Cancer; 2008 Mar; 7(2):144-8. PubMed ID: 18501075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]